Reaction
Quadriplegia reporting signals
As of the last recalculation, Quadriplegia appears in 2,026 FAERS reports alongside 36 co-occurring drug terms. The strongest observed disproportionality signal is METHYLPREDNISOLONE ACETATE (PRR 18.1).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Methylprednisolone Acetate | 14 | 18.1 | 18.1 |
| Ifosfamide | 34 | 16.5 | 16.5 |
| Bleomycin Sulfate | 14 | 14.0 | 14.0 |
| Interferon Beta-1B | 24 | 13.0 | 13.0 |
| Cytarabine | 60 | 10.5 | 10.6 |
| Ketoprofen | 13 | 10.2 | 10.2 |
| Bupivacaine | 9 | 9.9 | 9.9 |
| Vincristine Sulfate | 27 | 9.6 | 9.6 |
| Midazolam | 23 | 9.5 | 9.5 |
| Blinatumomab | 9 | 8.9 | 8.9 |
| Midazolam Hydrochloride | 23 | 8.9 | 8.9 |
| Ciprofolxacin | 59 | 8.7 | 8.7 |
| Ciprofloxacin Tablets | 59 | 8.7 | 8.7 |
| Dexamethasone Sodium Phosphate | 8 | 8.1 | 8.1 |
| Rocuronium Bromide | 9 | 7.9 | 7.9 |
| Fondaparinux Sodium | 6 | 7.6 | 7.6 |
| Pegaspargase | 9 | 7.6 | 7.6 |
| Baclofen | 60 | 7.3 | 7.4 |
| Amikacin | 12 | 7.3 | 7.3 |
| Propofol | 24 | 6.8 | 6.8 |
| Doxorubicin | 51 | 6.0 | 6.0 |
| Bendamustine Hcl | 9 | 6.0 | 6.0 |
| Fingolimod Hcl | 48 | 5.8 | 5.8 |
| Raltegravir | 9 | 5.6 | 5.6 |
| Etoposide | 39 | 5.5 | 5.5 |
| Alteplase | 8 | 5.5 | 5.5 |
| Axicabtagene Ciloleucel | 5 | 5.2 | 5.2 |
| Obinutuzumab | 8 | 5.0 | 5.0 |
| Gemcitabine Hydrochloride | 22 | 4.3 | 4.3 |
| Brentuximab Vedotin | 4 | 4.0 | 4.0 |
| Carfilzomib | 11 | 4.0 | 4.0 |
| Peginterferon Beta-1A | 5 | 3.9 | 3.9 |
| Abiraterone | 5 | 3.8 | 3.8 |
| Iohexol | 3 | 3.7 | 3.7 |
| Interferon Beta-1A | 65 | 3.5 | 3.5 |
| Natalizumab | 61 | 3.5 | 3.5 |